2023 Q4 Form 10-Q Financial Statement

#000119312523272400 Filed on November 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $6.781M $7.946M
YoY Change -1.11% -7.26%
Cost Of Revenue $7.570M $7.905M
YoY Change 1.42% 6.14%
Gross Profit -$789.2K $41.15K
YoY Change 29.98% -96.33%
Gross Profit Margin -11.64% 0.52%
Selling, General & Admin $1.347M $1.273M
YoY Change 13.93% 1.82%
% of Gross Profit 3093.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $354.7K $308.3K
YoY Change 10.92% -3.44%
% of Gross Profit 749.2%
Operating Expenses $1.347M $1.273M
YoY Change 13.93% -136.5%
Operating Profit -$2.137M -$1.232M
YoY Change 19.38% -126.74%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $25.20K $16.98K
YoY Change -55.07% 29.19%
Pretax Income -$2.111M -$1.215M
YoY Change 21.79% -126.29%
Income Tax -$568.4K -$251.0K
% Of Pretax Income
Net Earnings -$1.543M -$964.0K
YoY Change 17.54% -126.94%
Net Earnings / Revenue -22.75% -12.13%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.60 -$1.00
COMMON SHARES
Basic Shares Outstanding 966.1K shares 966.1K shares
Diluted Shares Outstanding 966.1K shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.158M $2.563M
YoY Change -53.12% -68.24%
Cash & Equivalents $1.387M $2.363M
Short-Term Investments $1.771M $200.0K
Other Short-Term Assets $960.9K $412.9K
YoY Change 127.29% -2.16%
Inventory $7.328M $8.795M
Prepaid Expenses
Receivables $4.394M $5.806M
Other Receivables $0.00 $0.00
Total Short-Term Assets $15.84M $18.19M
YoY Change -27.22% -27.2%
LONG-TERM ASSETS
Property, Plant & Equipment $11.67M $11.89M
YoY Change -1.66% -0.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $324.9K
YoY Change
Total Long-Term Assets $11.99M $11.89M
YoY Change 1.08% -0.14%
TOTAL ASSETS
Total Short-Term Assets $15.84M $18.19M
Total Long-Term Assets $11.99M $11.89M
Total Assets $27.83M $30.09M
YoY Change -17.23% -18.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $789.0K $1.008M
YoY Change 13.16% 12.3%
Accrued Expenses $644.9K $147.5K
YoY Change 96.63% -64.16%
Deferred Revenue $430.2K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.864M $2.234M
YoY Change 10.22% -35.92%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.864M $2.234M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.864M $2.479M
YoY Change -29.38% -43.5%
SHAREHOLDERS EQUITY
Retained Earnings $28.30M $29.94M
YoY Change -15.06% -14.08%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.922M $3.922M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $25.97M $27.61M
YoY Change
Total Liabilities & Shareholders Equity $27.83M $30.09M
YoY Change -17.23% -18.47%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$1.543M -$964.0K
YoY Change 17.54% -126.94%
Depreciation, Depletion And Amortization $354.7K $308.3K
YoY Change 10.92% -3.44%
Cash From Operating Activities $801.4K -$369.0K
YoY Change -194.04% -395.93%
INVESTING ACTIVITIES
Capital Expenditures $128.5K $189.6K
YoY Change -53.08% -139.15%
Acquisitions
YoY Change
Other Investing Activities -$1.552M $1.494M
YoY Change -2922.18% -70.35%
Cash From Investing Activities -$1.681M $1.304M
YoY Change 667.9% -71.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -96.62K -96.61K
YoY Change -54.54% -54.55%
NET CHANGE
Cash From Operating Activities 801.4K -369.0K
Cash From Investing Activities -1.681M 1.304M
Cash From Financing Activities -96.62K -96.61K
Net Change In Cash -975.9K 838.8K
YoY Change -23.97% -81.22%
FREE CASH FLOW
Cash From Operating Activities $801.4K -$369.0K
Capital Expenditures $128.5K $189.6K
Free Cash Flow $672.9K -$558.6K
YoY Change -159.76% -191.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Transition Report
DocumentTransitionReport
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Entity File Number
EntityFileNumber
000-01227
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
IL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-0904920
dei Entity Address Address Line1
EntityAddressAddressLine1
901 Frontenac Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Naperville
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60563
dei City Area Code
CityAreaCode
630
dei Local Phone Number
LocalPhoneNumber
357-8500
dei Security12b Title
Security12bTitle
Common Stock, par value $1.00 per share
dei Trading Symbol
TradingSymbol
CVR
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
966132 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2362982 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4045101 usd
CY2023Q3 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
200000 usd
CY2022Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
2691000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
146000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
160000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5806308 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4975137 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
8795196 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
9121230 usd
CY2023Q3 us-gaap Prepaid Taxes
PrepaidTaxes
616520 usd
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
509119 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
412899 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
422747 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
18193905 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
21764334 usd
CY2023Q3 us-gaap Land And Land Improvements
LandAndLandImprovements
1510513 usd
CY2022Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
1510513 usd
CY2023Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6835619 usd
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6758266 usd
CY2023Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
37890318 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
37080762 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
46236450 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
45349541 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
34345225 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33487748 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11891225 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11861793 usd
CY2023Q3 us-gaap Assets
Assets
30085130 usd
CY2022Q4 us-gaap Assets
Assets
33626127 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1007802 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
697235 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
778941 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
462332 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
147475 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
327961 usd
CY2023Q3 us-gaap Customer Advances And Deposits Current
CustomerAdvancesAndDepositsCurrent
300025 usd
CY2022Q4 us-gaap Customer Advances And Deposits Current
CustomerAdvancesAndDepositsCurrent
203717 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2234243 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1691245 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
244485 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
948084 usd
CY2023Q3 us-gaap Liabilities
Liabilities
2478728 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2639329 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1138096 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1138096 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
966132 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
966132 shares
CY2023Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1138096 usd
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1138096 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
447134 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
447134 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
29943270 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
33323666 usd
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
3922098 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3922098 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
27606402 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
30986798 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30085130 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33626127 usd
CY2023Q3 us-gaap Revenues
Revenues
7946172 usd
CY2022Q3 us-gaap Revenues
Revenues
8567785 usd
us-gaap Revenues
Revenues
24726828 usd
us-gaap Revenues
Revenues
26788879 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
7905019 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
7447877 usd
us-gaap Cost Of Revenue
CostOfRevenue
24537208 usd
us-gaap Cost Of Revenue
CostOfRevenue
22366372 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
41153 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
1119908 usd
us-gaap Gross Profit
GrossProfit
189620 usd
us-gaap Gross Profit
GrossProfit
4422507 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1273175 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1250385 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3890335 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3809970 usd
CY2023Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2022Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
4738394 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
4738394 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1273175 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
-3488009 usd
us-gaap Operating Expenses
OperatingExpenses
3890335 usd
us-gaap Operating Expenses
OperatingExpenses
-928424 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1232022 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4607917 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3700715 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
5350931 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16980 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13143 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
83030 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
35346 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-1215042 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
4621060 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-3617685 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
5386277 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-251000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1042000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-759000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1206000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-964042 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
3579060 usd
us-gaap Net Income Loss
NetIncomeLoss
-2858685 usd
us-gaap Net Income Loss
NetIncomeLoss
4180277 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.00
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
3.71
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2.96
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
4.33
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.00
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
3.71
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-2.96
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
4.33
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
966132 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
966132 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
966132 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
966132 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
966132 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
966132 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
966132 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
966132 shares
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.54
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.66
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
30986798 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-583137 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22
CY2023Q1 us-gaap Dividends
Dividends
212549 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
30191112 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1311506 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22
CY2023Q2 us-gaap Dividends
Dividends
212549 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
28667057 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-964042 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2023Q3 us-gaap Dividends
Dividends
96613 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
27606402 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
28969365 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
447313 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22
CY2022Q1 us-gaap Dividends
Dividends
212549 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
29204129 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
153904 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22
CY2022Q2 us-gaap Dividends
Dividends
212549 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
29145484 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
3579060 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22
CY2022Q3 us-gaap Dividends
Dividends
212549 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
32511995 usd
us-gaap Net Income Loss
NetIncomeLoss
-2858685 usd
us-gaap Net Income Loss
NetIncomeLoss
4180277 usd
us-gaap Depreciation
Depreciation
920430 usd
us-gaap Depreciation
Depreciation
960139 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-31500 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-4736096 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-703599 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-26000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-831171 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-930130 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
326034 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1401692 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-97553 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-75326 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
310567 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
204795 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
316609 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
328698 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-180486 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1209687 usd
us-gaap Increase Decrease In Customer Advances And Deposits
IncreaseDecreaseInCustomerAdvancesAndDeposits
96308 usd
us-gaap Increase Decrease In Customer Advances And Deposits
IncreaseDecreaseInCustomerAdvancesAndDeposits
-127094 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2733046 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-412742 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
949862 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
696073 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
31500 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5038240 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
2591000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
1245000 usd
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
100000 usd
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
1245000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1572638 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4342167 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
521711 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
637647 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-521711 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-637647 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1682119 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3291778 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4045101 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2036954 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2362982 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5328732 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7946172 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8567785 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24726828 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26788879 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font:10pt Arial;margin:0">2.  The Company extends credit on the basis of terms that are customary within our markets to various companies doing business primarily in the automotive industry.  The Company has a concentration of credit risk primarily within the automotive industry and in the Midwestern United States.  The Company has established an allowance for accounts that may become uncollectible in the future.  This estimated allowance is based in part on management's evaluation of the financial condition of the customer and historical experience.  The Company monitors its accounts receivable and charges to expense an amount equal to its estimate of potential credit losses.  The Company considers a number of factors in determining its estimates, including the length of time its trade accounts receivable are past due, the Company's previous loss history and the customer's current ability to pay its obligation.  The Company also considers current economic conditions, the economic outlook and industry-specific factors in its evaluation.  Accounts receivable balances are charged off against the allowance when it is determined that the receivable will not be recovered.</p>
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
161594 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
303906 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7946172 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8567785 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24726828 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26788879 usd
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
3460660 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4460071 usd
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
3073621 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2747427 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2801915 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2534732 usd
CY2023Q3 us-gaap Inventory Gross
InventoryGross
9336196 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
9742230 usd
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
541000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
621000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
8795196 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
9121230 usd

Files In Submission

Name View Source Status
cvr-20230930_cal.xml Edgar Link unprocessable
0001193125-23-272400-index-headers.html Edgar Link pending
0001193125-23-272400-index.html Edgar Link pending
0001193125-23-272400.txt Edgar Link pending
0001193125-23-272400-xbrl.zip Edgar Link pending
cvr-20230930.xsd Edgar Link pending
d866702d10q.htm Edgar Link pending
d866702dex311.htm Edgar Link pending
d866702dex312.htm Edgar Link pending
d866702dex321.htm Edgar Link pending
d866702dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cvr-20230930_def.xml Edgar Link unprocessable
cvr-20230930_lab.xml Edgar Link unprocessable
cvr-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
d866702d10q_htm.xml Edgar Link completed